Inogen announces third quarter 2023 financial results

Goleta, calif.--(business wire)--inogen, inc. (nasdaq: ingn), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the quarter ended september 30, 2023. third quarter 2023 and recent business highlights reported total revenue of $84.0 million, reflecting a decrease of 20.3% from the third quarter of 2022. completed acquisition of physio-assist sas, expanding inogen's global respiratory care presence by addre.
INGN Ratings Summary
INGN Quant Ranking